Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman’s risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three ...
A new contraceptive option provides a possible answer to an age-old question in family planning: how to address barriers that make it difficult for women to keep using contraception consistently.
Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associated with an increased risk of HIV acquisition. This study compares effects of ...
A National Dissemination Event of Key Findings on “A National Policy Landscape Analysis on DMPA SC as Self-Injection in Pakistan” took place on July 27, 2023, organized by RIZ Consulting and Jhpiego.